12 June 2017 - Two new drugs for the treatment of incurable kidney cancer have been approved for use by NHS Scotland.
The drugs have been shown in clinical trials to extend the lives of kidney cancer sufferers by several months compared with existing treatments.
Nivolumab and cabozantinib were accepted after being reviewed by the Scottish Medicines Consortium.